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Abstract
Background:  The clinical presentation of pregnancy-associated malaria, or PAM, depends
crucially on the particular epidemiological settings. This can potentially lead to an underestimation
of its overall burden on the female population, especially in regions prone to epidemic outbreaks
and where malaria transmission is generally low.
Methods: Here, by re-examining historical data, it is demonstrated how excess female mortality
can be used to evaluate the burden of PAM. A simple mathematical model is then developed to
highlight the contrasting signatures of PAM within the endemicity spectrum and to show how PAM
is influenced by the intensity and stability of transmission.
Results: Both the data and the model show that maternal malaria has a huge impact on the female
population. This is particularly pronounced in low-transmission settings during epidemic outbreaks
where excess female mortality/morbidity can by far exceed that of a similar endemic setting.
Conclusion: The results presented here call for active intervention measures not only in highly
endemic regions but also, or in particular, in areas where malaria transmission is low and seasonal.
Background
Malaria during pregnancy poses a significant threat to
both the mother and unborn child. For the mother, it
increases the risk of illness, severe anaemia and death; for
the unborn child it increases the risk of intra-uterine
growth retardation and low birth weight, spontaneous
abortion and stillbirth (reviewed in [1]). Numerous epi-
demiological studies have highlighted the various aspects
of malaria during pregnancy both in highly endemic
regions (mostly from sub-Saharan Africa) and in regions
where malaria transmission is low and sporadic (mainly
from Asia) (see e.g. [1-4]), and it has become clear that the
pathology of malaria during pregnancy and its evaluation
are highly dependent on the particular epidemiological
setting, due to differences in acquired immunity in
women reaching child-bearing age.
Acquired immunity to Plasmodium falciparum, the most
virulent agent of human malaria, is a gradual process by
which individuals build up a repertoire of protective
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immune responses over years of repeated exposure.
Although sterilizing immunity might never be attained,
people living in malaria endemic areas seem to acquire
protection against clinical malaria after a certain period of
exposure [5,6] and to severe disease after only a few infec-
tions [7]. In regions of sustained transmission, most
women of child-bearing age are, therefore, clinically
immune against the disease. Malarial infections during
pregnancy in these regions are usually associated with pla-
cental sequestration of parasites adhering to gly-
cosaminoglycan chondroitin sulphate A (CSA) through
the expression of var2csa [8-11], a member of the var gene
family which encodes the immunodominant surface anti-
gens and virulence factors PfEMP1 (P.falciparum  mem-
brane protein 1); this phenomenon is also known as
pregnancy-associated malaria or PAM.
Despite the vast overall diversity of var genes, serum sam-
ples from women of different geographical backgrounds
have shown that the antigens expressed in infected pla-
centas are highly conserved [12,13]. As a consequence,
immunity against PAM is rapid: usually after one or two
episodes, women will be protected during subsequent
pregnancies [14]. This is also supported by field studies
from highly endemic regions showing that PAM predom-
inantly affects primigravidae, i.e. women in their first
pregnancy, rather than multigravidae. This epidemiologi-
cal picture does not, however, extend to low transmission
areas where primi- and multigravid women can be equally
affected by PAM. Also, pregnant women from regions
with low and unstable transmission invariably become
symptomatic upon infection, and as a consequence it is
harder to differentiate between PAM and normal, i.e. non-
PAM, malaria unless placental samples are examined and
reported; this, however, is rarely the case in the published
literature.
The assessment of the extra burden caused by PAM, there-
fore, has to take into account the particular transmission
setting and is further complicated by at least two impor-
tant factors. Firstly, women from highly endemic regions
with placental malaria rarely show symptoms of disease
yet can develop life-threatening anaemia; this can poten-
tially lead to substantial underreporting of maternal and
foetal mortality due to placental malaria. Secondly, the
rates of mortality which can be attributed to PAM in low
transmission settings are hard to assess not only because
of the additional threat of clinical disease due to inade-
quate levels of protection but also because studies rarely
report the regions' equivalent (age- and exposure
adjusted) mortality rates for men or non-pregnant
women. Crucially also, there is still a great need to evalu-
ate the magnitude of the extra burden of PAM, and
malaria during pregnancy in general, during epidemic
outbreaks.
In this paper, historical data from the Punjab region in
former British India is re-examined and used to demon-
strate how to qualitatively assess the magnitude of PAM in
an epidemic transmission setting by means of excess
female mortality. The influence of the mode and intensity
of transmission is then investigated by means of a simple
mathematical model. Both the data and the model clearly
demonstrate that epidemic malaria, especially when inter-
mitted by periods of very low transmission, can have dev-
astating effects on the female population. This calls for
active intervention measures not only in highly endemic
but also, or even in particular, in regions of unstable
malaria transmission and those prone to epidemic out-
breaks.
Methods and Results
Historical data
Malaria in the semi-arid Punjab province of former British
India, currently the Punjab province of Pakistan and the
Punjab and Haryana States of India, showed severe epi-
demics associated with excess rainfall (Annual reports of
the Director of Public Health, Punjab 1902-1940,
[15,16]). Before the discovery of the malaria parasite and
when microscopically confirmed diagnosis was not read-
ily available, fever deaths during the malaria season
(October to December) have been used to estimate
malaria mortality. The "Epidemic Figure", a measure of
the annual (seasonal) intensity of transmission was intro-
duced to assist time series analysis. This ratio of fever
deaths during the malaria season (Oct-Dec) and deaths
during non-malariaous months was devised to minimize
the effects of administrative changes and qualities of the
health system over time. Spleen rates surveys, the percent-
age of school children under the age of 10 with a palpable
spleen, were introduced in the Punjab in 1914 to help
together with rainfall monitoring identification of areas at
risk of epidemics [17]. Figure 1 presents the spleen rate,
the Epidemic Figure, and relative female mortality (of all
age classes) for all districts in the Punjab for a 30-year
period between 1914 and 1943. The graphs clearly indi-
cate a good qualitative agreement between excess female
mortality and epidemic figure, as previously observed
[18], and the spleen rates conventionally used to assess
malaria prevalence. These parameters identify the highly
variable rate of malaria (transmission) over the years in
this region, including a particularly large epidemic out-
break in 1917; this supports the use of excess female mor-
tality rates as a proxy for qualitatively estimating the
additional burden of pregnancy-associated malaria upon
the female population.
Next, the female population is sub-divided to assess the
contributions of different age classes to the level of excess
mortality. Figure 2 shows the relative female to male fever
mortality by age group for all Punjab districts from 1908Malaria Journal 2009, 8:245 http://www.malariajournal.com/content/8/1/245
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to 1917. This figure clearly shows that that excess female
fever mortality peaks in the 10-14 years age group (coin-
ciding with the start of the female reproductive age in his-
torical India) and remains high over the female
reproductive years, only returning to levels comparable to
males in the age groups over 40 years. This is a clear indi-
cation of how malaria affects the group of reproductively
active females and primigravidae, i.e. those in the 10-14
years age class, in particular. Furthermore, the slope in the
decline of excess mortality between the 10-15 and the 30-
39 years age groups could signify the specific pregnancy
malaria associated immunity.
To investigate how previous exposure might influence
immunity to pregnancy-associated malaria within this
region of low and relatively unstable transmission one
can plot the female to male fever mortality data from the
1917 epidemic against the epidemic figure as a proxy of
the average malaria exposure prior to 1917 (in this case
the period 1902 to 1916). The scatter plot in Figure 3
shows how excess female mortality decreases with previ-
ous exposure which could be due to an increased level of
clinical immunity to malaria that protects women in
child-bearing age from severe and symptomatic illness but
is also indicative of acquired immunity specifically to pla-
cental malaria in that primi- and secundigarvidae are
more affected than multigravid women.
Taken together, the data is indicative how malaria and
specifically pregnancy-associated malaria affects women
in their reproductive age. Although primigravidae are the
ones mostly burdened by the disease, multigravid women
still contribute significantly to the excess in female mor-
tality, especially during a large epidemic outbreak that is
preceded by a long period of low transmission. Next, a
simple mathematical framework is developed to qualita-
tively investigate how the stability and intensity of trans-
mission affects the signature of PAM in terms of excess
female mortality (or morbidity in general).
Mathematical model
A schematic representation of the compartmental model
is shown as a flow diagram in Figure 4. Within this frame-
work, women are classified according to their nursing
period (number of pregnancies), from the proportion of
pre-reproductive girls, g, to the proportion of women
Spleen rate, Epidemic Figure (EF), and relative female mortality of all age groups between 1914 and 1943 for all districts in the  Punjab Figure 1
Spleen rate, Epidemic Figure (EF), and relative female mortality of all age groups between 1914 and 1943 for 
all districts in the Punjab. Relative female mortality (as % × 10, dotted line), defined as the ratio of female to male mortali-
ties, correlates well with both malaria indices spleen rate (dashed line) and Epidemic Figure (solid line). The values of the EF 
and relative female mortality for 1918, during the influenza epidemic, were estimated, based on the linear regression results 
with the spleen rate (r = 0.76 and r = 0.64 respectively).
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who, after a given number of pregnancies, H, have ceased
to be reproductively active, p; the proportion of females in
their i-th period of nursing are denoted by ni. Depending
on transmission intensity, pregnant women contract PAM
with probability , which can either be constant in time or
variable to reflect seasonal fluctuation and/or epidemic
outbreaks. It is assumed that after successful recovery
women are protected against further episodes of PAM. The
model can be described as the following set of differential
equations:
with
In the model, B  is the birth rate, 1/  the average life
expectancy, and  is the probability of dying as a result of
PAM. It is assumed that girls become sexually (reproduc-
tively) active at an average age of 1/m and bear children at
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Relative female to male fever mortality by age group for all Punjab districts (1908 to 1917) Figure 2
Relative female to male fever mortality by age group for all Punjab districts (1908 to 1917). Excess female fever 
mortality increase in the 5-9 age group, and remains high during the female reproductive age, only returning to levels compara-
ble to males in the age groups over 40 years. Standard deviations are highest for the 20-29 year age group. Apart from malaria, 
excess female fever mortality will be associated with perinatal bacterial infections. The slope in the decline of excess mortality 
between the 10 to 14 and the 30 to 39 year age group could signify a specific pregnancy-associated immunity.
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Relative female fever mortality in all Punjab's 26 districts for the epidemic year 1917 showing the effect of prior exposure on  PAM induced morbidity during epidemic outbreaks Figure 3
Relative female fever mortality in all Punjab's 26 districts for the epidemic year 1917 showing the effect of 
prior exposure on PAM induced morbidity during epidemic outbreaks. For malaria exposure of the districts prior to 
1917, the average annual Epidemic Figures (EF) between 1902 and 1916 for each district were used. One outlier (red diamond) 
was excluded from the polynomial regression (blue line). Spearman rank coefficient r = -0.645, R2 = 0.4595, P < 0.0005 (with 
outlier: r = -0.519, R2 = 0.3725, P < 0.007).
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Flow diagram showing the movements between different compartments within the model Figure 4
Flow diagram showing the movements between different compartments within the model. It is assumed that girls 
become reproductively active at an average age of 1/m. Depending on transmission intensity they contract malaria with proba-
bility , with a proportion a dying as a direct result of the disease. Women who do not contract PAM at their first or subse-
quent pregnancies remain susceptible and move between different classes of nursing at a rate c, where 1/c is the average length 
of time between succeeding pregnancies, until they cease to be reproductively active.
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an average interval of 1/c years. To include temporal vari-
ations in transmission,  was chosen to be generally time-
dependent (as given in equation (2)), where 0 is the
background transmission between the main transmission
seasons, s is the transmission intensity during a season or
the epidemic peak, and k  is a positive integer that
inversely determines the duration of the transmission
period (shorter for larger k). For simplicity, all other
parameters are assumed to be constant in time and parity.
Note, as malaria transmission is not explicitly model per
se, the above system solely represents excess disease (and
death) in the female population through PAM.
Within this framework, excess morbidity, E, is simply
defined by the rate pregnant women move out of g and
the susceptible classes ni multiplied by the probability of
contracting PAM, ; that is,
, where EP and EM denote
excess morbidity of the primi- and multigravidae classes,
respectively. Excess mortality could be defined in exactly
the same way and multiplying E  by the probability of
death as a result of PAM, ; however, as  is a circumstan-
tial parameter it suffices to use E as a measure of the bur-
den of PAM.
Stable transmission
Under the simplifying assumptions of constant birth and
death rate and transmission intensity, the model con-
verges towards a steady-state equilibrium (see Additional
file 1), which allows us to directly analyse excess female
morbidity, E, under changes in the level of transmission,
EE E m g c n PM i
iH
=+= +
=∑ 
1..
The effects of transmission intensity on excess female morbidity and its contribution from multigravidae Figure 5
The effects of transmission intensity on excess female morbidity and its contribution from multigravidae. As 
the rate of transmission, , goes up, the excess female morbidity, E (blue line), initially increases but plateaus at medium levels 
of . At the same time, the contribution from multigravidae to excess morbidity (red line) declines as a greater proportion of 
women will contract PAM during their earlier pregnancies. Parameter values:  = 1/40, m = 1/14, c = 1, B = 1/40,  = 0.1, H = 
10.
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. As shown in Figure 5, excess morbidity (blue line)
expectedly increases as transmission intensifies but pla-
teaus for medium to high levels of . At this point the con-
tribution from multigravid women (red line) declines to
zero and PAM is confined to the pool of women in their
first pregnancies. Note, the maximum in excess morbidity
in the multigravidae classes is not assumed at very low but
at intermediate transmission levels. This is simply due to
the fact that an initial increase in transmission inevitably
affects all classes before it reaches a level where PAM is
confined to women in their earlier and ultimately in their
first pregnancies.
Unstable transmission
To investigated how excess morbidity due to PAM is influ-
enced by temporal variation in malaria transmission, the
rate of transmission was decomposed into off- and on-
peak levels, 0 and s, respectively. Figures 6a-d demon-
strate the result of varying the background transmission,
0, on excess morbidity in primigravidae (6a and 6b) and
multigravidae (6c and 6d) by keeping peak the transmis-
sion intensity 0 + s constant. Comparing the maximas in
excess morbidity for the two different transmission set-
tings (low and high level of background transmission)
reveals that the peak in excess morbidity in primigravidae,
EP, remains unaffected by a change in background trans-
mission and is only determined by 0 + s. In contrast,
multigravidae exhibit a significant reduction in peak
excess morbidity when background transmission is
higher. This can be explained by the inverse relationship
between transmission intensity and the contribution of
multigravidae to the excess in female morbidity. In other
words, when transmission is low, a greater proportion of
females go throughout their nursing stages unaffected by
PAM and are thus fully susceptible during epidemic out-
breaks. Importantly, excess morbidity during an outbreak
significantly exceeds that of a comparable stable, endemic
setting where  = 0 + s. Figure 6e and 6f illustrate a direct
comparison of excess morbidity in primi- and multigravi-
dae, EP and EM, respectively, under the two different trans-
mission scenarios. This clearly demonstrates that major
epidemic outbreaks, which are preceded by a period of
low transmission, will cause a considerably higher ratio in
female to male morbidity/mortality than what can be
expected in endemic regions with intense yet stable trans-
mission. Therefore, not only does temporal variability of
transmission change the signature of excess female mor-
bidity compared to a year-round stable infection risk, it
can also severely enhance the burden of PAM on the
female population, especially when the level of exposure
between epidemics is relatively low. Figure 7 illustrates
the effect of varying the level of background transmission
on the maximum in excess morbidity during seasonal/
epidemic outbreaks and is in good qualitative agreement
with the data from the Punjab region, shown as inset
(same as Figure 3).
Discussion
The adverse effects of malaria during pregnancy have long
been recognized, but not until relatively recently have
they gained much attention in terms of public health and
intervention measures. It is clear from earlier work that
malaria during pregnancy takes a different dynamic as the
intensity of transmission changes through location and
time [1,2,19]. There are also significant differences in its
pathology and it is, therefore, useful to distinguish
between placental malaria, or PAM, which specifically
affects pregnant women and is caused by placental
sequestration of P. falciparum parasitized red blood cells,
and 'normal' malaria infections during pregnancy which
can also, yet to a lesser degree, be caused by other Plasmo-
dium species with adverse consequences for the mother
and unborn child [20].
Placental malaria is the most common cause for low birth
weight (LBW) in high transmission areas. It has been
identified as the single greatest risk factor for neonatal
mortality and contributor to infant mortality with an esti-
mated 7-fold increase in the risk of still birth. Further-
more, it has recently been reported that children born to
mothers with placental malaria also have an increased risk
of malaria during their first few years of life [21]. In unsta-
ble and low transmission settings, on the other hand,
malaria infections are more likely to cause clinical disease.
Consequently, preterm delivery caused by febrile episodes
is the biggest risk factor for low birth weight (LBW) in chil-
dren in these regions. It appears, therefore, that in low
endemic and unstable transmission settings mothers are
the ones mostly affected by malarial infections during
pregnancy, whereas in regions where transmission is
intense, the burden is carried mainly by the foetus. How-
ever, women with symptomatic infections are more likely
to seek out medical attention (if at all available), thus
potentially reducing the risk of both severe disease and the
establishment of placental malaria. This could lead to an
underestimation of the risk of PAM in low and unstable
transmission regions, and may account for the low meas-
ures reported in those settings [3,22,23].
Here, a method of using (historical) longitudinal data on
excess female mortality has been used to qualitatively
assess the impact of PAM on the female population in a
malaria endemic area with considerable variations in
transmission intensities. Although at this stage this can
only be used as a proxy for the absolute level of mortality
attributable to PAM, it clearly indicates a significant con-
tribution of pregnancy-associated malaria to female mor-
tality, especially during epidemic outbreaks. This
approach is based on the observation that the ratio ofMalaria Journal 2009, 8:245 http://www.malariajournal.com/content/8/1/245
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Figure 6 (see legend on next page)
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female to male mortality is not constant over time but
shows a strong correlation with transmission intensity.
That is, if extra female deaths were simply due to compli-
cations during labour and/or infections during pregnancy,
this number would expectedly be relatively constant and
independent of the intensity of malaria transmission. In
addition, excess female mortality is negatively and (possi-
bly) non-linearly correlated with prior exposure to
malaria as would be expected if it were attributable to
PAM. Finally, the significant increase in excess mortality
during an epidemic outbreak, compared to non-epidemic
years, clearly demonstrates the existence and damaging
effect of pregnancy specific malaria in a region where
transmission is moderate and unstable.
A simple mathematical model demonstrates how overall
female morbidity may be expected to increase with trans-
mission intensity while shifting the contribution from
women of all gravidity towards those in their first preg-
nancy. In low transmission settings there is a chance that
women reach a non-reproductive stage without ever con-
tracting PAM, whereas in hyper-endemic regions most
Effect of seasonal transmission on excess morbidity in primigravidae and multigravidae at different background transmission  rates Figure 6 (see previous page)
Effect of seasonal transmission on excess morbidity in primigravidae and multigravidae at different back-
ground transmission rates. The left panel illustrates a scenario of low background transmission between seasonal (or epi-
demic) outbreaks (0 = 0.01), whereas the right panel depicts a situation with moderate level of year-round transmission (0 = 
0.2). The top row (a, b) shows the excess morbidity from primigravidae; the middle row (c, d) shows the excess morbidity of 
multigravid women, clearly indicating that higher background transmission significantly reduces excess morbidity from multi-
gravid women during epidemic outbreaks. The bottom row (e, f) compares the maximum in excess morbidity from primi- and 
multigravidae (EM and EP, respectively) for the two background transmission rates with a stable transmission setting under 
equivalent maximum transmission rates, clearly demonstrating the effect of unstable transmission on multigravid women. 
Parameter values:  = 1/40, m = 1/14, c = 1, B = 1/40,  = 0.1, H = 10, k = 10.
The effect of prior exposure on PAM induced morbidity during epidemic outbreaks Figure 7
The effect of prior exposure on PAM induced morbidity during epidemic outbreaks. High year-round transmission 
results in most women experiencing PAM some time during their first pregnancies and offers a high degree of protection 
within the multigravidae class. Low levels of transmission on the other hand leave women of all parities vulnerable to the dis-
ease, causing a high degree of excess morbidity during large epidemics. Parameter values:  = 1/40, m = 1/14, c = 1, B = 1/40,  
= 0.1, H = 10, k = 10, S = 0.5-0.
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women will contract the disease during their first preg-
nancy. Interestingly though, it was found that the contri-
bution from multigravidae to excess female morbidity is
not linear but peaks at low to medium levels of transmis-
sion and, as expected, diminishes towards to upper end of
the endemicity spectrum. It is also clear from this analysis
that the total average number of pregnancies impacts the
magnitude of morbidity among females, at least in
regions of low and unstable malaria (see Additional file
1). Thus, a reduction in the average number of pregnan-
cies (for example through education on birth control)
could have an impact on mortality in areas where trans-
mission intensity is moderate but would have little effect
in hyperendemic situations. This may, however, be altered
by the spread of HIV as recent reports suggest that HIV
infection can impair humoral immunity to placental type
VSA [24,25]. If so, the age structure (and overall inci-
dence) of PAM could shift in a direction, even in hyperen-
demic areas, that would warrant intervention through
birth control.
The greatest effect of PAM on the female population
observed within this framework was by incorporating sea-
sonal variations in transmission intensity. Given suffi-
ciently low background transmission rates, many women
will go through successive pregnancies without getting
infected, leaving a significant proportion of the reproduc-
tively active female population still susceptible to PAM. As
a result, and in accordance with the data presented here,
the observable excess in female morbidity during epi-
demic outbreaks is significantly higher than within a sta-
ble transmission setting and equivalent transmission
intensity, and even more so as the level of transmission in
the period preceding an epidemic is especially low.
These data also support the current conception of PAM as
being particularly severe among females with low expo-
sure to non-PAM malaria as compared to those living in
hyperendemic areas. There are a number of reasons why
this may be the case. In hyperendemic areas, women of
childbearing age will typically have protective antibodies
to the other PfEMP1 proteins encoded by the var genes of
parasites expressing placental binding var2csa, and this
may protect them from disease while allowing infection
of the placenta (which still has severe consequences for
the foetus); in areas of low transmission, women of child-
bearing age may not have immune responses against the
other PfEMP1 proteins encoded by the infecting parasite
and thus may experience disease as well as infection. Indi-
viduals living in areas of high transmission may also have
antibodies to VAR2CSA itself without having sustained a
placental infection [26], although it remains to be shown
if the antibody levels reported are protective against dis-
ease. Finally, there are of course a very large range of other
immune responses that could prevent an outcome of
severe complicated malaria upon infection with parasites
expressing placental binding var2csa. However, as men
and women alike will lack these forms of protective
immunity in areas of low transmission, the excess mortal-
ity attributed to PAM strongly implies that placental infec-
tion itself can greatly increase the chances of death among
individuals with incomplete immunity. Indeed, if immu-
nity to severe disease is acquired upon one or two infec-
tions [7], the analyses presented in this paper indicates
that this form of immunity clearly does not extend to
PAM. The unusually conserved nature of VAR2CSA makes
it an attractive vaccine candidate, but until this vaccine
becomes available, ongoing and future prevention meas-
ures, such as intermittent preventive treatment (IPTp)
against malaria, in particular during pregnancy (see e.g.
[27,28]), have to be urgently employed not only in
regions of extensive levels of transmission but equally in
regions where malaria is more sporadic.
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